--- title: "Tenon Medical (TNON) news: offering and convertible notes" url: "https://aibio.space/companies/tenon-medical/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "TNON offering and convertible notes news: Tenon Medical obtains investor waiver to increase at-the-market sales. Tenon Medical, Inc." --- TNON Tenon Medical, Inc. NASDAQ · United States # Tenon Medical (TNON) news TNON offering and convertible notes news Financings · 2026-10-16 ## [Tenon Medical obtains investor waiver to increase at-the-market sales](https://aibio.space/news/tenon-medical-obtains-investor-waiver-increase-market-sales/) The investor waived limits that would have blocked a larger at-the-market offering, in exchange for a new warrant at $5.02 per share. WallachBeth Capital LLC also waived its rights under the sales agreement. ## Latest Tenon Medical news 1. 2026-09-11 Financings [Tenon Medical announces warrant inducement for $2,872,338.58 gross](https://aibio.space/news/tenon-medical-announces-warrant-inducement-2-872-338-58-gross/) Holders exercised 572,179 existing warrants for cash and received new warrants for 858,269 shares at $5.02 per share. WallachBeth Capital acted as financial advisor, and the closing was expected on or about September 14, 2026. 2. 2026-09-09 Debt Financing [Tenon Medical repays convertible notes ahead of September 11 maturity](https://aibio.space/news/tenon-medical-repays-convertible-notes-ahead-september-11-maturity/) Tenon repaid in full original issue discount senior convertible promissory notes with an aggregate principal balance of approximately $5.16 million, issued March 11, 2026. The release names no noteholder or agent. 3. 2026-08-28 Financings [Tenon Medical prices $3.0 million private placement with warrants](https://aibio.space/news/tenon-medical-prices-3-0-million-private-placement-warrants/) Tenon Medical agreed to sell 597,610 shares, or pre-funded warrants, to an institutional investor, with warrants for up to 1,058,517 more shares. WallachBeth Capital LLC is the exclusive placement agent. 4. 2026-08-13 Company Updates [Tenon Medical reports second quarter 2026 revenue of $1.3 million](https://aibio.space/news/tenon-medical-reports-second-quarter-2026-revenue-1-3-million/) Revenue rose 127% from a year earlier and gross margin reached 64%. Cash was $1.7 million at June 30, 2026, before a $4.2 million offering that closed on July 1. 5. 2026-06-30 Financings [Tenon Medical prices $4.2 million public offering with warrants](https://aibio.space/news/tenon-medical-prices-4-2-million-public-offering-warrants/) The offering is priced at $0.38 per share and common warrants. WallachBeth Capital LLC is the sole placement agent, and part of the proceeds will repay convertible notes. ## Tenon Medical at a glance - **Ticker**: TNON - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $1.7 million ### Related companies - [Fortrea Holdings](https://aibio.space/companies/fortrea/) NASDAQ: FTRE - [ALR Technologies SG](https://aibio.space/companies/alr-technologies-sg/) OTC: ALRTF - [EBR Systems](https://aibio.space/companies/ebr-systems/) OTC: EBRCZ - [MDxHealth SA](https://aibio.space/companies/mdxhealth/) NASDAQ: MDXH - [Embecta](https://aibio.space/companies/embecta/) NASDAQ: EMBC - [ILLUMINA, INC.](https://aibio.space/companies/illumina/) NASDAQ: ILMN - [FITLIFE BRANDS, INC.](https://aibio.space/companies/fitlife-brands/) NASDAQ: FTLF - [AVITA Medical](https://aibio.space/companies/avita-medical/) NASDAQ: RCEL ### Also on NASDAQ - [Conexeu Sciences](https://aibio.space/companies/conexeu-sciences/) CNXU - [Hyperfine](https://aibio.space/companies/hyperfine/) HYPR - [Anteris Technologies Global](https://aibio.space/companies/anteris-technologies-global/) AVR - [Capricor Therapeutics](https://aibio.space/companies/capricor-therapeutics/) CAPR - [Clearmind Medicine](https://aibio.space/companies/clearmind-medicine/) CMND - [Retension Pharmaceuticals](https://aibio.space/companies/retension-pharmaceuticals/) RTSN ## Tenon Medical annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$3.9 million](https://www.sec.gov/Archives/edgar/data/1560293/000121390026035707/) | [$3.3 million](https://www.sec.gov/Archives/edgar/data/1560293/000121390026035707/) | | Research and development | [$2.1 million](https://www.sec.gov/Archives/edgar/data/1560293/000121390026035707/) | [$2.6 million](https://www.sec.gov/Archives/edgar/data/1560293/000121390026035707/) | | Net income (loss) | [-$12.6 million](https://www.sec.gov/Archives/edgar/data/1560293/000121390026035707/) | [-$13.7 million](https://www.sec.gov/Archives/edgar/data/1560293/000121390026035707/) | | Cash from operations | [-$10.7 million](https://www.sec.gov/Archives/edgar/data/1560293/000121390026035707/) | [-$9.9 million](https://www.sec.gov/Archives/edgar/data/1560293/000121390026035707/) | | Cash and equivalents | [$3.8 million](https://www.sec.gov/Archives/edgar/data/1560293/000121390026089258/) | [$6.5 million](https://www.sec.gov/Archives/edgar/data/1560293/000121390026035707/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $1.7 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Tenon Medical Has Tenon Medical raised money recently? Our latest story on this, dated Oct 16, 2026: "Tenon Medical obtains investor waiver to increase at-the-market sales". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/tenon-medical-obtains-investor-waiver-increase-market-sales/). Has Tenon Medical sold convertible notes? Our latest story on this, dated Sep 9, 2026: "Tenon Medical repays convertible notes ahead of September 11 maturity". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/tenon-medical-repays-convertible-notes-ahead-september-11-maturity/). What is the ticker symbol of Tenon Medical? Tenon Medical, Inc. trades under the ticker TNON on NASDAQ. Where is Tenon Medical listed? Tenon Medical, Inc. is listed on NASDAQ. Which country or territory is Tenon Medical listed under? Our directory records Tenon Medical, Inc. under United States. Does aibio.space cover Tenon Medical? aibio.space lists Tenon Medical, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. What was Tenon Medical's revenue last year? $3.9 million for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is Tenon Medical profitable? Tenon Medical, Inc. reported a net loss of $12.6 million for the fiscal year ended Dec 31, 2025, and used $10.7 million of cash in operations, per its annual report to the SEC. How much does Tenon Medical spend on research and development? $2.1 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Tenon Medical have? $1.7 million in cash at Jun 30, 2026, per its 10-Q. What is the latest Tenon Medical (TNON) stock news? Our latest story on Tenon Medical, dated Oct 16, 2026: "Tenon Medical obtains investor waiver to increase at-the-market sales". The investor waived limits that would have blocked a larger at-the-market offering, in exchange for a new warrant at $5.02 per share. WallachBeth Capital LLC also waived its rights under the sales agreement. [Source](https://aibio.space/news/tenon-medical-obtains-investor-waiver-increase-market-sales/). How long will Tenon Medical's cash last? From our story of Sep 9, 2026: Its forward-looking statements list the ability to continue as a going concern, regaining and keeping Nasdaq listing compliance, and raising more capital on acceptable terms or at all as risks. [Source](https://aibio.space/news/tenon-medical-repays-convertible-notes-ahead-september-11-maturity/). How can I follow Tenon Medical (TNON) news? Press Follow on this page to add Tenon Medical to your Following list, or subscribe to the aibio.space newsletter. We have published 6 stories naming Tenon Medical so far, in Company Updates, Debt Financing, Financings. ## Investor discussion: Tenon Medical Members talk about Tenon Medical (TNON). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Tenon Medical, newest first. Each line links the filing it comes from. 1. 2026-10-16 Financings Reported a financing. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/1560293/000121390026110252/ea0308890-424b5_tenon.htm) 2. 2026-08-11 Financings Set up an at-the-market program to sell shares over time. SEC Form S-3. [Source](https://www.sec.gov/Archives/edgar/data/1560293/000121390026087891/ea0294906-s3_tenon.htm) 3. 2026-08-10 Listings Reported a reverse stock split. SEC Form 8-K (Items 3.03,5.03,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1560293/000121390026087352/ea030142401ex99-1.htm) 4. 2026-07-24 Listings Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.07). [Source](https://www.sec.gov/Archives/edgar/data/1560293/000121390026081438/ea0299237-8k_tenon.htm) 5. 2026-07-10 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 8.01). [Source](https://www.sec.gov/Archives/edgar/data/1560293/000121390026077274/ea0297192-8k_tenon.htm) 6. 2026-06-23 Listings Asked shareholders to approve a reverse stock split. SEC Form DEF 14A. [Source](https://www.sec.gov/Archives/edgar/data/1560293/000121390026070828/ea0295058-def14a_tenon.htm) 7. 2026-06-22 Financings Reported a financing. SEC Form S-1. [Source](https://www.sec.gov/Archives/edgar/data/1560293/000121390026070685/ea0295255-s1_tenon.htm) 8. 2026-06-12 Listings Asked shareholders to approve a reverse stock split. SEC Form PRE 14A. [Source](https://www.sec.gov/Archives/edgar/data/1560293/000121390026068266/ea0294342-pre14a_tenon.htm) 9. 2026-05-22 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). [Source](https://www.sec.gov/Archives/edgar/data/1560293/000121390026060662/ea0291962-8k_tenon.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:TNON on TradingView](https://www.tradingview.com/symbols/NASDAQ-TNON/). ## Listing details Tenon Medical, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker TNON, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Tenon Medical, Inc. - **Ticker**: TNON - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/tenon-medical/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Tenon Medical (TNON) news: offering and convertible notes", 2026-10-31, https://aibio.space/companies/tenon-medical/